For condition: Psoriasis
Adult’s Psoriasis Study (5 Years)
Study Summary
Who Can Participate?
Adults aged 40 or above with moderate to severe plaque psoriasis may participate.
Inclusion Criteria
• Psoriasis on 10% or greater body surface area
• One or more of the following should apply
– Current cigarette smoker (vaping does not qualify)
– Diagnosis of hypertension or dyslipidemia
– Use of blood pressure-lowering medications or lipid-lowering medications
– Type 1 or type 2 diabetes
– Have had heart surgery, cardiac arrest, or stroke
– Obesity (body mass index ≥ 30 kg/m2)
– Family history of heart attacks in a relative younger than 55 or a female immediate family member younger than 65
Participant Information
• Participate and receive study treatment at no cost
• Regular visits with study doctors who specialise in treating psoriasis (up to 13 visits)
• Will receive either an investigative oral or subcutaneous treatment (study drug)
• Reimbursement for study-related expenses may be provided
How Long Will The Study Last?
• Approximately 5 years
For more information about this trial, please visit ClinicalTrials.gov
